WaferGen Biosystems Announces New Service Using SmartChip Real-Time PCR System

WaferGen Biosystems, Inc. (OTC:WGBS) (BULLETIN BOARD: WGBS) , a leading developer of state-of-the-art genetic analysis systems, today announced a new, innovative service for gene-expression profiling of thousands of genes using the SmartChip(TM) Real-Time PCR System. By taking advantage of the SmartChip Real-Time PCR system, WaferGen will offer universities, pharmaceutical and diagnostic companies a service that utilizes pathway-specific gene panels to discover and validate new biomarkers.

The company also announced today that it is moving to a new facility to support the SmartChip services and the expansion of manufacturing and R&D functions. The new WaferGen SmartChip Service will be made available to a few select customers in December and made more broadly available in the first quarter of 2010. The SmartChip Service offerings will be expanded early next year to include a miRNA expression panel. Researchers will get early access to the technology and the benefit of new and upcoming gene panels. In addition, academic researchers can get preliminary data at a reasonable cost to submit for grants to complete more advanced studies.

"Our new service, run by our experienced scientists, will introduce users to the throughput benefits of SmartChip to maximize the discovery of new biomarkers," said Alnoor Shivji, Chairman and CEO, WaferGen. "For the first time, researchers can interrogate thousands of genes in a single run using Real-Time PCR and detect gene expression differences that could be missed using microarray technology."

The WaferGen SmartChip Service is targeted at scientists involved in the discovery and validation of molecular biomarkers. The initial product to be run on the SmartChip platform is the SmartChip Human Oncology Gene Panel that provides pathway based gene expression profiling for Oncology. It may also be used for Immunology, Metabolic and Stem Cell research. The 5,184 nano-well SmartChip uses a small amount of biological material to query a thousand genes in a single sample, enabling discovery of biomarkers while saving researchers time and money. By applying Quantitative Real-Time PCR Expression Profiling, the SmartChip system combines the gene expression profiling of microarrays with the sensitivity and dynamic range of Real-Time PCR, the gold standard of gene expression studies. The 27 built-in controls offer added quality assurance to the results.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    WaferGen Biosystems, Inc.. (2019, March 18). WaferGen Biosystems Announces New Service Using SmartChip Real-Time PCR System. AZoNano. Retrieved on April 15, 2024 from https://www.azonano.com/news.aspx?newsID=14756.

  • MLA

    WaferGen Biosystems, Inc.. "WaferGen Biosystems Announces New Service Using SmartChip Real-Time PCR System". AZoNano. 15 April 2024. <https://www.azonano.com/news.aspx?newsID=14756>.

  • Chicago

    WaferGen Biosystems, Inc.. "WaferGen Biosystems Announces New Service Using SmartChip Real-Time PCR System". AZoNano. https://www.azonano.com/news.aspx?newsID=14756. (accessed April 15, 2024).

  • Harvard

    WaferGen Biosystems, Inc.. 2019. WaferGen Biosystems Announces New Service Using SmartChip Real-Time PCR System. AZoNano, viewed 15 April 2024, https://www.azonano.com/news.aspx?newsID=14756.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.